Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Risk factors for lymphedema in breast cancer survivors, the Iowa Women's Health Study

Identifieur interne : 005425 ( Main/Exploration ); précédent : 005424; suivant : 005426

Risk factors for lymphedema in breast cancer survivors, the Iowa Women's Health Study

Auteurs : Rehana L. Ahmed [États-Unis] ; Kathryn H. Schmitz [États-Unis] ; Anna E. Prizment [États-Unis] ; Aaron R. Folsom [États-Unis]

Source :

RBID : Pascal:12-0019486

Descripteurs français

English descriptors

Abstract

Risk factors for lymphedema and related arm symptoms in breast cancer (BC) survivors have not been examined using a large prospective population-based cohort. The Iowa Women's Health Study (IWHS) collected self-reported data for diagnosed lymphedema in 2004, and data for cancer diagnosis, treatment, behavioral and health characteristics between 1986 and 2003. We studied 1,287 women, aged 55-69 at baseline, who developed unilateral BC: n = 104 (8%) with diagnosed lymphedema, n = 475 (37%) with arm symptoms but without diagnosed lymphedema, and n = 708 without lymphedema. Age- and multivariate-adjusted logistic regression models examined risk factors for lymphedema and related arm symptoms (OR [95% confidence interval]). The mean time between BC and the 2004 survey was 8.1 ± 5.0 (mean ± SD) years. After multivariate adjustment, the following cancer characteristics were positively associated with lymphedema: tumor stage (regional vs. in situ: 3.92 [1.61-9.54]), number of excised nodes (highest vs. lowest quintile: 3.52 [1.32-9.34], Ptrend = 0.003), tumor-positive nodes (yes vs. no 2.12 [1.19, 3.79]), and adjuvant chemotherapy (yes vs. no: 3.05 [1.75-5.30]). Several health characteristics were positively associated with lymphedema: baseline body mass index (highest vs. lowest tertile: 3.24 [1.70-6.21]), waist and hip circumference, and general health (fair/poor vs. excellent: 3.44 [1.30-9.06]). Positive associations with arm symptoms were number of excised nodes (highest vs. lowest quintile: 2.38 [1.41-.03], Ptrend = 0.007), axillary radiation (yes vs. no: 1.72 [1.15-2.57]), and baseline general health (fair/poor vs. excellent: 4.27 [2.60-7.00]). In the IWHS, obesity, poorer general health, and markers of more advanced cancer were risk factors for lymphedema and related arm symptoms in BC survivors.

Url:


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Risk factors for lymphedema in breast cancer survivors, the Iowa Women's Health Study</title>
<author>
<name sortKey="Ahmed, Rehana L" sort="Ahmed, Rehana L" uniqKey="Ahmed R" first="Rehana L." last="Ahmed">Rehana L. Ahmed</name>
<affiliation wicri:level="2">
<inist:fA14 i1="01">
<s1>Department of Dermatology, University of Minnesota, Mayo Mail Code 98, 420 Delaware Street SE</s1>
<s2>Minneapolis, MN 55455-0392</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<region type="state">Minnesota</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Schmitz, Kathryn H" sort="Schmitz, Kathryn H" uniqKey="Schmitz K" first="Kathryn H." last="Schmitz">Kathryn H. Schmitz</name>
<affiliation wicri:level="2">
<inist:fA14 i1="02">
<s1>Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology, University of Pennsylvania, 921 Blockley Hall, 423 Guardian Drive</s1>
<s2>Philadelphia, PA 19104</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Prizment, Anna E" sort="Prizment, Anna E" uniqKey="Prizment A" first="Anna E." last="Prizment">Anna E. Prizment</name>
<affiliation wicri:level="2">
<inist:fA14 i1="03">
<s1>Division of Epidemiology and Community Health, The University of Minnesota, 1300 S Second Street, Suite 300</s1>
<s2>Minneapolis, MN 55454</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<region type="state">Minnesota</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Folsom, Aaron R" sort="Folsom, Aaron R" uniqKey="Folsom A" first="Aaron R." last="Folsom">Aaron R. Folsom</name>
<affiliation wicri:level="2">
<inist:fA14 i1="03">
<s1>Division of Epidemiology and Community Health, The University of Minnesota, 1300 S Second Street, Suite 300</s1>
<s2>Minneapolis, MN 55454</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<region type="state">Minnesota</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">12-0019486</idno>
<date when="2011">2011</date>
<idno type="stanalyst">PASCAL 12-0019486 INIST</idno>
<idno type="RBID">Pascal:12-0019486</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000129</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000828</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000142</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000142</idno>
<idno type="wicri:doubleKey">0167-6806:2011:Ahmed R:risk:factors:for</idno>
<idno type="wicri:Area/Main/Merge">005464</idno>
<idno type="wicri:source">PMC</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4091732</idno>
<idno type="RBID">PMC:4091732</idno>
<idno type="wicri:Area/Pmc/Corpus">003744</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">003744</idno>
<idno type="wicri:Area/Pmc/Curation">003743</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">003743</idno>
<idno type="wicri:Area/Pmc/Checkpoint">002D58</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">002D58</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="wicri:Area/PubMed/Corpus">002533</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002533</idno>
<idno type="wicri:Area/PubMed/Curation">002533</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002533</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002533</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002533</idno>
<idno type="wicri:Area/Ncbi/Merge">004524</idno>
<idno type="wicri:Area/Ncbi/Curation">004524</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">004524</idno>
<idno type="wicri:doubleKey">0167-6806:2011:Ahmed R:risk:factors:for</idno>
<idno type="wicri:Area/Main/Merge">004C07</idno>
<idno type="wicri:Area/Main/Curation">005425</idno>
<idno type="wicri:Area/Main/Exploration">005425</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Risk factors for lymphedema in breast cancer survivors, the Iowa Women's Health Study</title>
<author>
<name sortKey="Ahmed, Rehana L" sort="Ahmed, Rehana L" uniqKey="Ahmed R" first="Rehana L." last="Ahmed">Rehana L. Ahmed</name>
<affiliation wicri:level="2">
<inist:fA14 i1="01">
<s1>Department of Dermatology, University of Minnesota, Mayo Mail Code 98, 420 Delaware Street SE</s1>
<s2>Minneapolis, MN 55455-0392</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<region type="state">Minnesota</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Schmitz, Kathryn H" sort="Schmitz, Kathryn H" uniqKey="Schmitz K" first="Kathryn H." last="Schmitz">Kathryn H. Schmitz</name>
<affiliation wicri:level="2">
<inist:fA14 i1="02">
<s1>Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology, University of Pennsylvania, 921 Blockley Hall, 423 Guardian Drive</s1>
<s2>Philadelphia, PA 19104</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Prizment, Anna E" sort="Prizment, Anna E" uniqKey="Prizment A" first="Anna E." last="Prizment">Anna E. Prizment</name>
<affiliation wicri:level="2">
<inist:fA14 i1="03">
<s1>Division of Epidemiology and Community Health, The University of Minnesota, 1300 S Second Street, Suite 300</s1>
<s2>Minneapolis, MN 55454</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<region type="state">Minnesota</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Folsom, Aaron R" sort="Folsom, Aaron R" uniqKey="Folsom A" first="Aaron R." last="Folsom">Aaron R. Folsom</name>
<affiliation wicri:level="2">
<inist:fA14 i1="03">
<s1>Division of Epidemiology and Community Health, The University of Minnesota, 1300 S Second Street, Suite 300</s1>
<s2>Minneapolis, MN 55454</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName>
<region type="state">Minnesota</region>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Breast cancer research and treatment</title>
<title level="j" type="abbreviated">Breast cancer res. treat.</title>
<idno type="ISSN">0167-6806</idno>
<imprint>
<date when="2011">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Breast cancer research and treatment</title>
<title level="j" type="abbreviated">Breast cancer res. treat.</title>
<idno type="ISSN">0167-6806</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Body Composition</term>
<term>Breast Neoplasms (complications)</term>
<term>Breast Neoplasms (pathology)</term>
<term>Breast Neoplasms (therapy)</term>
<term>Breast cancer</term>
<term>Epidemiology</term>
<term>Female</term>
<term>Health</term>
<term>Human</term>
<term>Humans</term>
<term>Iowa</term>
<term>Iowa (epidemiology)</term>
<term>Lymph Nodes (pathology)</term>
<term>Lymphedema</term>
<term>Lymphedema (epidemiology)</term>
<term>Lymphedema (etiology)</term>
<term>Middle Aged</term>
<term>Neoplasm Staging</term>
<term>Risk Factors</term>
<term>Risk factor</term>
<term>Survivor</term>
<term>Survivors</term>
<term>Woman</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adulte d'âge moyen</term>
<term>Composition corporelle</term>
<term>Facteurs de risque</term>
<term>Femelle</term>
<term>Humains</term>
<term>Iowa (épidémiologie)</term>
<term>Lymphoedème (épidémiologie)</term>
<term>Lymphoedème (étiologie)</term>
<term>Noeuds lymphatiques (anatomopathologie)</term>
<term>Stade de la tumeur</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Survivants</term>
<term>Tumeurs du sein ()</term>
<term>Tumeurs du sein (anatomopathologie)</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en">
<term>Iowa</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr">
<term>Noeuds lymphatiques</term>
<term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en">
<term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en">
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Breast Neoplasms</term>
<term>Lymph Nodes</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en">
<term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>Iowa</term>
<term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr">
<term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Body Composition</term>
<term>Female</term>
<term>Humans</term>
<term>Middle Aged</term>
<term>Neoplasm Staging</term>
<term>Risk Factors</term>
<term>Survivors</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Adulte d'âge moyen</term>
<term>Composition corporelle</term>
<term>Facteur risque</term>
<term>Epidémiologie</term>
<term>Facteurs de risque</term>
<term>Femelle</term>
<term>Humains</term>
<term>Lymphoedème</term>
<term>Cancer du sein</term>
<term>Homme</term>
<term>Stade de la tumeur</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Survivant</term>
<term>Iowa</term>
<term>Femelle</term>
<term>Adulte</term>
<term>Femme</term>
<term>Santé</term>
<term>Survivants</term>
<term>Tumeurs du sein</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Homme</term>
<term>Adulte</term>
<term>Femme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Risk factors for lymphedema and related arm symptoms in breast cancer (BC) survivors have not been examined using a large prospective population-based cohort. The Iowa Women's Health Study (IWHS) collected self-reported data for diagnosed lymphedema in 2004, and data for cancer diagnosis, treatment, behavioral and health characteristics between 1986 and 2003. We studied 1,287 women, aged 55-69 at baseline, who developed unilateral BC: n = 104 (8%) with diagnosed lymphedema, n = 475 (37%) with arm symptoms but without diagnosed lymphedema, and n = 708 without lymphedema. Age- and multivariate-adjusted logistic regression models examined risk factors for lymphedema and related arm symptoms (OR [95% confidence interval]). The mean time between BC and the 2004 survey was 8.1 ± 5.0 (mean ± SD) years. After multivariate adjustment, the following cancer characteristics were positively associated with lymphedema: tumor stage (regional vs. in situ: 3.92 [1.61-9.54]), number of excised nodes (highest vs. lowest quintile: 3.52 [1.32-9.34], P
<sub>trend</sub>
= 0.003), tumor-positive nodes (yes vs. no 2.12 [1.19, 3.79]), and adjuvant chemotherapy (yes vs. no: 3.05 [1.75-5.30]). Several health characteristics were positively associated with lymphedema: baseline body mass index (highest vs. lowest tertile: 3.24 [1.70-6.21]), waist and hip circumference, and general health (fair/poor vs. excellent: 3.44 [1.30-9.06]). Positive associations with arm symptoms were number of excised nodes (highest vs. lowest quintile: 2.38 [1.41-.03], P
<sub>trend</sub>
= 0.007), axillary radiation (yes vs. no: 1.72 [1.15-2.57]), and baseline general health (fair/poor vs. excellent: 4.27 [2.60-7.00]). In the IWHS, obesity, poorer general health, and markers of more advanced cancer were risk factors for lymphedema and related arm symptoms in BC survivors.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Minnesota</li>
<li>Pennsylvanie</li>
</region>
</list>
<tree>
<country name="États-Unis">
<region name="Minnesota">
<name sortKey="Ahmed, Rehana L" sort="Ahmed, Rehana L" uniqKey="Ahmed R" first="Rehana L." last="Ahmed">Rehana L. Ahmed</name>
</region>
<name sortKey="Folsom, Aaron R" sort="Folsom, Aaron R" uniqKey="Folsom A" first="Aaron R." last="Folsom">Aaron R. Folsom</name>
<name sortKey="Prizment, Anna E" sort="Prizment, Anna E" uniqKey="Prizment A" first="Anna E." last="Prizment">Anna E. Prizment</name>
<name sortKey="Schmitz, Kathryn H" sort="Schmitz, Kathryn H" uniqKey="Schmitz K" first="Kathryn H." last="Schmitz">Kathryn H. Schmitz</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005425 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 005425 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:12-0019486
   |texte=   Risk factors for lymphedema in breast cancer survivors, the Iowa Women's Health Study
}}

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024